Baseimmune

About Us

Baseimmune is a discovery stage biotech company focused on antigen discovery and vaccine development. The technology is based on a computational platform deciphering pathogen evolution to design cross-protective vaccines.

Our multi-target and gene-agnostic antigen selection approach tackles emerging and highly complex pathogens that had been failed by traditional approaches. By taking evolution into consideration, our vaccines have broader coverage and remain effective even when the pathogen mutates.

Team

Founded in 2019 by a technical team of vaccine and software developers, Baseimmune is accelerating discovery of novel and cross-protective vaccines. Our founders pioneered the use of computational approaches to design cross-protective vaccines against various infectious diseases while at the Jenner Institute University of Oxford with two candidates in clinical trials.

Leadership

Joshua Blight

Ariane C. Gomes

Phillip Kemlo

Co-founder, CEO

Co-founder, CSO

Co-founder, CTO

Meet the team

Board of Directors

Jamie

Macfarlane

Creator Fund

Hussein

Kanji

Hoxton Ventures

Joshua

Blight

Baseimmune

Ariane

Gomes

Baseimmune

Phillip

Kemlo

Baseimmune

Advisory Board

Danny

Goovaerts

Prof. Jake

Baum

Prof. Molly Stevens

Veterinary Commercial Advisor

Scientific Advisor

Pipeline

Our early-stage pipeline includes two human vaccines against Malaria (BSI002) and a pancoronavirus vaccine (BSI001), and a veterinary vaccine against African Swine Fever (BSI001). All candidates are currently being tested as mRNA/LNP or viral vectors.

Human

Pan-Coronavirus Vaccine

DISCOVERY

PRECLINICAL

BSI002

Universal Malaria Vaccine

BSI003

Veterinary

FEASIBILITY

EARLY-STAGE DEVELOPMENT

Universal African Swine Fever Vaccine

BSI001

News & Careers

Q&A - Who are we?

meet the Baseimmune team and find out what we do

Read more ➤

> more news

Career Opportunities

Join the team to harness the power of our computational platform to design and create variant-proof vaccines. Check our careers page for available positions.

See Opportunities

Working with world-class